Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation

J Thorac Cardiovasc Surg. 2004 Jun;127(6):1812-3. doi: 10.1016/j.jtcvs.2003.12.021.

Authors

Ann Verrijckt¹, François Proulx, Sylvain Morneau, Suzanne Vobecky

Affiliation

¹ Department of Pediatrics, Section of Intensive Care Medicine, ainte-Justine Hospital, University of Montreal, Montreal, Quebec, Canada. annverrijckt@yahoo.com

PMID: 15173742
DOI: 10.1016/j.jtcvs.2003.12.021

No abstract available

Publication types

Case Reports

MeSH terms

Cardiac Surgical Procedures / adverse effects*
Cardiac Surgical Procedures / methods
Extracorporeal Membrane Oxygenation / adverse effects*
Extracorporeal Membrane Oxygenation / methods
Factor VIIa / therapeutic use*
Fatal Outcome
Hemostatic Techniques
Humans
Infant, Newborn
Male
Postoperative Hemorrhage / diagnosis
Postoperative Hemorrhage / drug therapy*
Risk Assessment
Severity of Illness Index
Transposition of Great Vessels / diagnosis
Transposition of Great Vessels / surgery
Transposition of Great Vessels / therapy*
Treatment Outcome

Substances

Factor VIIa